Phase 3 Clinical Trial to Evaluate of the Efficacy and Safety of DW9801 in Patients With Primary Dysmenorrhea

NCT04541134 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Dysmenorrhea

Interventions

DRUG: Pelubiprofen 45mg
DRUG: Placebo

Sponsor

Daewon Pharmaceutical Co., Ltd.